Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2025)
Zhengye Biotechnology Holding's (ZYBT) quarterly Enterprise Value came in at $55.4 million in Q4 2025, down 79.89% quarter-over-quarter from $275.6 million in Q2 2025.
Powered by 
Analysis
Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Enterprise Value for 1 consecutive years, with $55.4 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Enterprise Value changed N/A year-over-year to $55.4 million in Q4 2025; TTM through Dec 2025 was $55.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $55.5 million, changed N/A from the prior year.
- Enterprise Value was $55.4 million for Q4 2025 at Zhengye Biotechnology Holding, down from $275.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at $275.6 million in Q2 2025 and troughed at $55.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 39.99 Bn | 39.79 Bn | 779.09 Mn |
| 2 | Zoetis | 30.50 Bn | 28.83 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.44 Bn | 10.91 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.34 Mn | 67.24 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |